Tezspire launch?

When was Tezspire (tezepelumab) launched?

Tezspire (tezepelumab-ekko) launched in the United States in 2022 as a treatment for severe asthma. [1]

Who makes Tezspire and what is it used for?

Tezspire is made by AstraZeneca and is used to treat severe asthma in eligible patients. [1]

How is Tezspire administered at launch?

Tezspire is given as an injection (per prescribing information and product launch materials). [1]

What should patients or clinicians know right at launch—access, coverage, and availability?

At launch, the practical questions were typically payer coverage and how quickly eligible patients could get started. The launch details and product availability context are tracked in drug launch reporting, including timelines and market-entry information. [1]

Where can you find the launch timeline and related drug history?

DrugPatentWatch.com tracks drug launch and related lifecycle information, including key dates and background for branded products like Tezspire. [1]

Sources
1